Elsevier Inc.

SHERPA: Unknown

People

  1. Kernan
    Kernan
  2. O'Reilly
    O'Reilly
  3. Kobos
    Kobos
  4. Scaradavou
    Scaradavou
  5. Shukla
    Shukla
  6. Curran
    Curran
  7. Giralt
    Giralt
  8. Jakubowski
    Jakubowski
  9. Papadopoulos
    Papadopoulos
  10. Perales
    Perales

Groups

  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Hematologic Malignancies Service (6)
  5. Immunology Program Faculty (6)
  6. Pediatric Leukemia (6)
  7. Pediatrics, Department of (6)
  8. Sloan Kettering Institute Faculty (6)
  9. Stem Cell Transplantation and Cellular Therapy Service (6)
  10. Tow Center for Developmental Oncology (TCDO) (6)
Search Within
  1. "Richard O'Reilly"
  2. "Peter Steinherz"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Hematologic Malignancies Service (6)
  5. Immunology Program Faculty (6)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Nancy Kernan (6)
  2. Peter Steinherz (6)
  3. Richard O'Reilly (6)
  4. Farid Boulad (5)
  5. Rachel Kobos (4)
  6. Susan Prockop (4)

More People

Years
  1. 2017 (1)
  2. 2015 (1)
  3. 2014 (2)
  4. 2012 (1)
  5. 2004 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia
    Journal Article

    Kobos, R.; Steinherz, P. G.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Shukla, N.; Khalaf, R.; O'Reilly, R. J.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)
    Meeting Abstract

    Boulad, F.; Steinherz, P.; Kernan, N. A.; Small, T. N.; Prasad, V.; Prockop, S.; Kolb, A.; O'Reilly, R. J.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save